We are live on
!
Find out more
A
Astrantus Portfolio holdings
AUM
$59.4M
This Fund
S&P 500
This Quarter
Est. Return
-5.76%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$59.4M
AUM Growth
-$74.2M
(-56%)
Cap. Flow
-$69.6M
Cap. Flow
% of AUM
-117%
Top 10 Holdings %
Top 10 Hldgs %
8.09%
Holding
327
New
119
Increased
16
Reduced
36
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$523K |
| 2 |
Home Depot
HD
|
+$520K |
| 3 |
Wells Fargo
WFC
|
+$519K |
| 4 |
Unilever
UL
|
+$515K |
| 5 |
Bank of America
BAC
|
+$514K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.49M |
| 2 |
Zebra Technologies
ZBRA
|
+$1.49M |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.45M |
| 4 |
Duke Energy
DUK
|
+$1.44M |
| 5 |
Alibaba
BABA
|
+$1.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.49% |
| 2 | Healthcare | 14.97% |
| 3 | Technology | 14.75% |
| 4 | Industrials | 12.84% |
| 5 | Consumer Discretionary | 12.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Haemonetics
HAE
$4.73B
| – | – |
-3,800
| Closed | -$202K |
|
227
Halliburton
HAL
$30.1B
| – | – |
-19,775
| Closed | -$452K |
|
|
HBI
228
DELISTED
Hanesbrands
HBI
| – | – |
-12,642
| Closed | -$211K |
|
229
HCA Healthcare
HCA
$90.5B
| – | – |
-2,456
| Closed | -$631K |
|
230
HDFC Bank
HDB
$119B
| – | – |
-12,328
| Closed | -$401K |
|
231
Highwoods Properties
HIW
$3.44B
| – | – |
-12,400
| Closed | -$553K |
|
232
Humana
HUM
$46.3B
| – | – |
-1,300
| Closed | -$603K |
|
233
Integra LifeSciences
IART
$1.31B
| – | – |
-3,100
| Closed | -$208K |
|
234
Interactive Brokers
IBKR
$43.4B
| – | – |
-47,400
| Closed | -$941K |
|
235
Illumina
ILMN
$32.6B
| – | – |
-1,474
| Closed | -$546K |
|
236
Infosys
INFY
$48.8B
| – | – |
-29,974
| Closed | -$759K |
|
237
Invitation Homes
INVH
$17.4B
| – | – |
-8,925
| Closed | -$405K |
|
238
Intuitive Surgical
ISRG
$132B
| – | – |
-3,100
| Closed | -$1.11M |
|
239
Jacobs Solutions
J
$17.8B
| – | – |
-3,957
| Closed | -$456K |
|
240
KKR & Co
KKR
$97.6B
| – | – |
-9,421
| Closed | -$702K |
|
241
Kilroy Realty
KRC
$4.21B
| – | – |
-9,173
| Closed | -$610K |
|
242
Leidos
LDOS
$17.7B
| – | – |
-10,700
| Closed | -$951K |
|
243
Lear
LEA
$8.26B
| – | – |
-1,406
| Closed | -$257K |
|
244
L3Harris
LHX
$48.9B
| – | – |
-4,500
| Closed | -$960K |
|
245
Lockheed Martin
LMT
$130B
| – | – |
-2,782
| Closed | -$989K |
|
246
Mastercard
MA
$521B
| – | – |
-1,600
| Closed | -$575K |
|
247
Manhattan Associates
MANH
$13B
| – | – |
-1,833
| Closed | -$285K |
|
248
Moody's
MCO
$89.2B
| – | – |
-3,300
| Closed | -$1.29M |
|
249
MongoDB
MDB
$35.9B
| – | – |
-700
| Closed | -$371K |
|
|
250
Meta Platforms (Facebook)
META
$1.47T
| – | – |
-4,300
| Closed | -$1.45M |
|
Similar funds
AAI
TLCM
LSC
ALFA
IMF
DCM
SCMU
EA
Astrantus's Q1 2022 Portfolio in Review
As of Q1 2022, Astrantus held 327 positions worth $59.4M, down 56% from $134M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
Astrantus withdrew a net $69.6M in Q1 2022, closing 155 positions and reducing 36 holdings. Its most notable exit was TSMC, an estimated $1.49M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Astrantus opened a new position in Bank of New York Mellon worth $457K.
- Astrantus's largest Q1 2022 buy was Bank of New York Mellon: 9,200 shares worth $457K.
- Astrantus added most to AT&T in Q1 2022, an estimated $282K increase.
- Astrantus's biggest Q1 2022 reduction was CVS Health, cutting an estimated $1.1M.
- Astrantus fully exited TSMC in Q1 2022, selling an estimated $1.49M.
- Astrantus's ten largest holdings make up 8.1% of its $59.4M portfolio in Q1 2022.
- Astrantus opened 119 new positions and closed 155 in Q1 2022.
- Astrantus's portfolio value fell 56% quarter-over-quarter to $59.4M.
Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.